Chapter Five - About Training and Memory: NK-Cell Adaptation to Viral Infections
Introduction
Natural killer (NK) cells are lymphocytes belonging to the family of innate lymphoid cells (Annunziato, Romagnani, & Romagnani, 2015), and since their discovery as cytotoxic effector cells of the innate immune system in 1975 (Kiessling, Klein, & Wigzell, 1975), our knowledge of NK cells has progressed abundantly. Initially, their functional characterization was focused on the killing of malignantly transformed and virally infected cells and has over time been extended to their contribution to and regulation of host immune responses (Vivier, Tomasello, Baratin, Walzer, & Ugolini, 2008). The key functions of NK cells include direct killing of target cells by release of granules containing the cytotoxic proteins perforin and granzymes and secretion of their signature cytokine interferon (IFN)-γ as well as of tumor necrosis factor (TNF), granulocyte–macrophage colony-stimulating factor (GM-CSF), and chemokine (C–C motif) ligands CCL3 and CCL4. As such, NK cells contribute to host defense as direct effectors and immunoregulators.
The functionality of NK cells is regulated by the integration of signals from a broad range of activating and inhibitory receptors, which, unlike the T-cell receptor (TCR), do not undergo rearrangement. Activating receptors such as NKG2D, DNAM-1, and the natural cytotoxicity receptors (NCRs, namely NKp46, NKp30, and NKp44) sense ligands, which are upregulated during cellular stress, tumor transformation, or viral infection (Moretta et al., 2001). CD16, the low affinity receptor for the Fc part of IgG, enables NK cells to recognize and be activated by antibody-coated target cells, a phenomenon known as antibody-dependent cell cytotoxicity (ADCC). The majority of NK-cell activating receptors contain short intracellular domains, which do not possess signaling capacity. Instead, the cytoplasmic regions associate with signaling chains such as CD3ζ, FcɛRγ, and DAP12, which in turn contain immunoreceptor tyrosine-based activation motifs (ITAMs), and thus transmit their signals similar to the TCR (Lanier, 2008). However, some exceptions with different signaling properties exist. Human NKG2D selectively couples to DAP10 containing a YINM motif (Wu et al., 1999), the family of SLAM-related receptors contains immunoreceptor tyrosine-based switch motifs (ITSMs) (Watzl, 2014), and DNAM-1 can directly recruit the tyrosine kinase Fyn and the serine-threonine kinase PKC via signal-transducing motifs in its cytoplasmic domain (Shibuya et al., 1998, Shirakawa et al., 2005). Engagement of activating receptors or CD16 by their respective ligands on target cells induces signaling, leading to the release of cytotoxic mediators and the secretion of cytokines and chemokines by the activated NK cells. In addition, NK cells express the receptors for different cytokines, among which are the receptors for type I IFNs, interleukin (IL)-12, IL-15, and IL-18. Stimulation via cytokines induces phosphorylation of signaling molecules of the JAK/STAT families downstream of most cytokine receptors (O'Shea & Plenge, 2012) or mediates signaling through the adaptor MyD88 for the IL-1R/IL-18R (Fitzgerald & O'Neill, 2000). Ultimately, cytokine receptor signaling yields in secretion of chemokines and cytokines by NK cells and enhances their functionality against cellular targets (Fauriat, Long, Ljunggren, & Bryceson, 2010). The majority of inhibitory receptors such as those belonging to the killer cell immunoglobulin-like receptor (KIR) family in humans, to the C-type lectin-like superfamily of Ly49 receptors in mice and CD94/NKG2A in both species bind to major histocompatibility complex (MHC) class I molecules to prevent autoreactivity against host cells, while allowing the detection of cells lacking MHC class I expression (missing self), which often occurs as an immune evasion strategy during viral infection or malignant transformation. In contrast to activating receptors, engagement of inhibitory receptors induces phosphorylation of immunoreceptor tyrosine-based inhibition motifs (ITIMs), directly and indirectly counterbalancing stimulation through activating signals (Lanier, 2008). Importantly, these inhibitory receptors confer education, that is, functional competence, and NK cells lacking the expression of inhibitory receptors remain in a hyporesponsive state toward target cells, thus ensuring tolerance (Goodridge, Onfelt, & Malmberg, 2015).
The majority of activating receptors including NKp30, NKp46, DNAM-1, and NKG2D are uniformly expressed on NK cells in the periphery. Conversely, other inhibitory or activating receptors belonging to the KIR, Ly49, or CD94/NKG2 families are stochastically distributed on different NK-cell subsets. This combinatorial coexpression pattern of activating and inhibitory receptors determines the NK-cell receptor repertoire. State-of-the-art mass cytometry estimated the presence of up to 30,000 phenotypically distinct subpopulations of NK cells within single human individuals (Horowitz et al., 2013). Monitoring shifts and deviations in the NK-cell repertoire under varying pathogenic, environmental, or experimental conditions has enabled to recognize how the NK-cell pool adapts in response to viral infections.
The role of NK cells in the defense against viral infections has been extensively studied in animal models. In particular, the analysis of the NK-cell response to the herpesvirus murine cytomegalovirus (MCMV) has provided important insights as to how NK cells can specifically recognize virus-infected cells and contribute to the control of viral infections (Scalzo & Yokoyama, 2008). Infection of inbred mouse lines enabled the identification of strains with differing resistance to MCMV infection due to variations of a host locus, named Cmv1, which confers protection toward MCMV infection in an NK cell-dependent fashion (Scalzo, Fitzgerald, Simmons, La Vista, & Shellam, 1990). Genetic analyses revealed that Cmv1 maps to the distal region of mouse chromosome 6 in the NK-cell gene complex (NKC) (Scalzo et al., 1992). Further studies demonstrated that the NK-cell receptor Ly49H, encoded within the Cmv1 locus, is responsible for MCMV resistance in C57BL/6 mice (Depatie et al., 1997, Forbes et al., 1997). Ly49H is an activating receptor of the C-type lectin-like superfamily, which associates with the signaling adaptor DAP12 (Smith, Wu, Bakker, Phillips, & Lanier, 1998) and recognizes the MHC class I-like glycoprotein m157 derived from the Smith and K181 MCMV laboratory strains. Introduction of Ly49H in susceptible mice is sufficient to confer resistance to MCMV infection (Arase et al., 2002, Brown et al., 2001, Daniels et al., 2001, Lee et al., 2001, Lee et al., 2003, Smith et al., 2002). However, analysis of MCMV isolates from wild-type mice revealed a large variety of m157 sequence variants displaying low binding to Ly49H and maintaining the ability to efficiently replicate in C57BL/6 mice, indicating that MCMV resistance displayed by different mouse lines is also dependent on the virus strain (Corbett et al., 2011, Voigt et al., 2003). m157 from Smith and K181 MCMV strains can also bind to the inhibitory receptor Ly49I in 129/J mice, while the MCMV G1F strain binds to both the activating receptor Ly49H and the inhibitory receptor Ly49C from C57BL/6 mice, suggesting that m157 may have evolved as an immune evasion protein engaging NK-cell inhibitory receptors (Arase et al., 2002).
Rare cases of human genetic diseases have allowed investigating the clinical importance of NK cells during viral infections, since patients suffering from combined NK-cell deficiencies present with severe and disseminated infections, especially caused by β-Herpesviridae such as varicella zoster virus (VZV), human (H)CMV, Epstein–Barr virus (EBV), and herpes simplex virus (HSV) (Biron et al., 1989, Orange, 2013). Further supporting the role of human NK cells in the defense against viruses, control of acute HCMV infection, which coincided with expansion of a distinct NK-cell subset, was observed in a pediatric SCID patient in the absence of T cells (Kuijpers et al., 2008).
Altogether, human and mouse studies have highlighted the key role of NK cells in controlling infections by herpesviruses, in particular by CMV.
Section snippets
NK-Cell Adaptations to Viral Infections
It is well established that viral infection can activate T-cell responses and generate immunological memory, which is able to protect the host against subsequent infections. The initial antigen encounter triggers activation of selected T-cell clones, which receive signal 1 by interaction of their TCR with its cognate peptide presented by MHC class I and signal 2 by costimulatory signals mediated through CD28 (Williams & Bevan, 2007). Signaling delivered by exposure to proinflammatory cytokines,
Functional Imprinting of Adaptive NK Cells
The critical role of adaptive NK cells for viral control is highlighted by the seminal observation that Ly49H is responsible for MCMV resistance in C57BL/6 mice and following studies, as discussed in Section 1.2. In humans, although control of acute HCMV infection in a pediatric SCID patient was associated with a typical expansion of NKG2C+ adaptive NK cells (Kuijpers et al., 2008), the protective role of such adaptive NK cells in humans remains elusive. Even analysis of NKG2C-deficient
Epigenetic Remodeling as Hallmark of Immune Training and Memory
Since the first description of the “epigenotype” as a complex connection of genotype and phenotype in Drosophila more than 70 years ago (Waddington, 1942), regulation of gene expression beyond the DNA sequence level has emerged as the pioneering field of epigenetics. In cellular biology, global changes in epigenetic landscapes are most recognized during programmed differentiation from progenitor/precursor cells into their respective progeny. Epigenetic reprogramming is also an adaptive
Training and Cross-Reactive Memory: Consequences for Heterologous Immunity
In this paragraph, we would like to discuss whether and how priming and imprinting of NK cells during a primary infection can drive heterologous immunity. The term heterologous immunity refers to immunity that can develop to one pathogen after a host has had exposure to nonidentical pathogens (Welsh, Che, Brehm, & Selin, 2010). This concept explains previous seminal data of acquired resistance to heterologous pathogens (Mackaness, 1964) and is supported by epidemiologic and immunological
Outlook and Outstanding Questions
In the last years our understanding of how NK cells adapt to CMV infection has dramatically changed our way of thinking, further blurring the schematic differences between innate and adaptive immunity. These findings paved the way for new fields of research, which will hopefully help to answer many open questions: what is the relative contribution of inflammatory signals vs specific recognition of viral antigens in driving phenotypic, functional, and epigenetic imprinting of adaptive NK cells
Acknowledgments
We thank Marina Babic, Kerstin Juelke, Timo Rueckert, and Josefine Dunst for insightful comments and helpful discussions. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grants SFB 650 and RO 3565 to C.R. C.R. is supported by the DFG Heisenberg grant RO 3565/1, and Q.H. is supported by the Leibniz Association (Leibniz Graduate School for Rheumatology).
References (147)
- et al.
Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo
Immunity
(2000) - et al.
The 3 major types of innate and adaptive cell-mediated effector immunity
The Journal of Allergy and Clinical Immunology
(2015) - et al.
Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation
Experimental Cell Research
(1997) - et al.
Bone-marrow-resident NK cells prime monocytes for regulatory function during infection
Immunity
(2015) - et al.
Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy
Biology of Blood and Marrow Transplantation
(2009) - et al.
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
Blood
(2013) - et al.
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Blood
(2010) - et al.
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
Blood
(2009) - et al.
Infection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus
Cell Reports
(2012) - et al.
High-resolution linkage map in the proximity of the host resistance locus Cmv1
Genomics
(1997)